PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming
Molecular Carcinogenesis · 2023
DOI: 10.1002/mc.23531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2023. Verfasst von Yingchao Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest human malignancies characterized by late‐stage diagnosis, drug resistance, and poor prognosis. Pyruvate dehydrogenase kinase 1 (PDK1) plays an important role in regulating the metabolic reprogramming of cancer cells. However, its expression, function, and regulatory mechanisms of PDK1 in ESCC have not been reported. In this study, we found that PDK1 silence and dichloroacetic acid (DCA) significantly inhibited the growth of ESCC cells and induced cell apoptosis. Interestingly, PDK1 is a direct target of miR‐6516‐5p, and miR‐6516‐5p/PDK1 axis suppressed the growth of ESCC cell by inhibiting glycolysis. Moreover, DCA and cisplatin (cis‐diammine‐dichloroplatinum, DDP) synergistically inhibited the progression and glycolysis ability of ESCC cells both in vitro and in vivo by increasing oxidative stress via the inhibition of the Keap1/Nrf2 signaling pathway. And, Tert‐butylhydroquinone (TBHQ), a specific activator of the Keap1/Nrf2 signaling, could diminish the synergic antitumor effects of DCA and DDP on ESCC cells. Collectively, our findings indicate that PDK1 may regulate the progression of ESCC by metabolic reprogramming, which provides new strategy for the treatment of ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
- Department of Pathology, Xuchang Central Hospital Affiliated to Henan University of Science and Technology, Xuchang, Henan, China.
ORCID-Profile: Shanshan Ma
Zitieren
APA
Ma, Y., Zhang, X., Han, X., Hao, Z., Ji, R., Li, J., Guo, W., Zhang, Y., Guan, F., & Ma, S. (2023). PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23531
Vancouver
Ma Y, Zhang X, Han X, Hao Z, Ji R, Li J, et al. PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming. Molecular Carcinogenesis. 2023. doi:10.1002/mc.23531
BibTeX
@article{Ma2023,
author = {Ma, Yingchao and Zhang, Xishen and Han, Xiao and Hao, Zhizhong and Ji, Rong and Li, Jianhui and Guo, Wenna and Zhang, Yanting and Guan, Fangxia and Ma, Shanshan},
title = {PDK1 regulates the progression of esophageal squamous cell carcinoma through metabolic reprogramming},
journal = {Molecular Carcinogenesis},
year = {2023},
doi = {10.1002/mc.23531}
}
EUVIMED